ID Management A/S’s Edwards Lifesciences EW Stock Holding History

ID Management A/S’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$480K	Hold	14,442	–	–	0.15%	101
2016 Q1	$425K	Hold	14,442	–	–	0.14%	111
2015 Q4	$380K	Hold	14,442	–	–	0.12%	116
2015 Q3	$342K	Buy	+14,442	New	+$349K	0.15%	104
2015 Q1	$142K	Buy	+6,000	New	+$135K	0.07%	195

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

ID Management A/S's EW Position: Q2 2016 in Review

ID Management A/S held its Edwards Lifesciences (EW) position steady in Q2 2016 at 14,442 shares worth $480K. The position accounts for 0.15% of the portfolio, ranked #101.

ID Management A/S first reported a position in EW in Q1 2015 and has held it in 5 quarters since. 693 funds tracked by Wall St. Rank hold EW as of Q2 2016.

ID Management A/S held 14,442 shares of Edwards Lifesciences worth $480K as of Q2 2016.
ID Management A/S left its Edwards Lifesciences share count unchanged in Q2 2016.
Edwards Lifesciences made up 0.15% of ID Management A/S's portfolio in Q2 2016, its #101 holding.
ID Management A/S first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 5 quarters since.
693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2016.

Based on ID Management A/S's 13F filing for Q2 2016, filed 14 Jul 2016.